Study of endostatin, tumstatin and PEDF, the natural angiogenesis inhibitors, potential in avasculargenic therapy

Study of endostatin, tumstatin and PEDF, the natural angiogenesis inhibitors, potential in avasculargenic therapy

Show other versions (1)

<p><strong>Purpose:</strong> To evaluate the potential of endostatin, tumstatin and PEDF in avasculargenic therapy.</p><p><br /><strong>Methods:</strong> The avasculargenic potential of the natural angiogenesis inhibitors was explored on the model of a...

Full description

Bibliographic Details
Main Authors: V. G. Likhvantseva, E. V. Arutyunyan, A. I. Miroshnikov, A. Yu. Salihov, O. V. Belous, K. D. Kurtshalidze, R. S. Esipov, K. A. Bejrahova, V. N. Stepanenko
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2014-07-01
Series:Oftalʹmologiâ
Subjects:
neovascularization of cornea
endostatin
tumstatin
PEDF
Online Access:http://www.ophthalmojournal.com/index.php/opht/article/view/80

Internet

http://www.ophthalmojournal.com/index.php/opht/article/view/80

Similar Items